Trial reportAsian Pacific journal of cancer prevention : APJCP2025
Assessing the Impact of Pharmacists' Interventions on Preventing and Resolving Drug-Related Problems in Cancer Pain Management.
Trial report in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Factors associated with cancer pain management behavior among pharmacists: a cross-sectional study based on the COM-B model.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveDrug-related problems (DRPs) hinder patients from fully benefiting from pharmacotherapy, with persistent pain in cancer patients remaining a significant issue. This study aimed to evaluate the clinical outcomes and medication cost changes resulting from pharmacists' interventions in managing DRPs associated with cancer pain.
methodsA randomized controlled study was conducted in a scholarly medical institution. Hospitalized cancer patients experiencing pain were randomly assigned to either the Intervention Category (IC) or Control Category (CC). The Pharmaceutical Care Network Europe (PCNE) classification system was utilized to categorize DRPs related to analgesic use. Pharmacists conducted assessments focusing on pain relief, incidence of adverse drug reactions (ADRs), and cost savings from DRP resolutions. Data on DRP types, causes, proposed interventions, and outcomes of pharmacist recommendations were collected and analyzed.
resultsA total of 180 participants were enrolled and evenly distributed between the IC and CC groups. In the IC, pharmacists identified 68 DRPs in 49 participants, averaging 0.8 DRPs per patient. A total of 150 pharmacist-led interventions were proposed. By the third day of treatment, the IC demonstrated significantly greater analgesic relief compared to the CC. Additionally, 35 DRP interventions in the IC led to measurable cost reductions.
conclusionPharmacist-led interventions for cancer patients experiencing pain effectively addressed drug-related problems, enhanced pain management, and contributed to reduced medication costs. Integrating clinical pharmacy services into cancer pain management can lead to improved therapeutic outcomes and resource optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.